- Sales Intelligence: Healthcare
- Posts
- Weekly Newsletter - 11.20.2024
Weekly Newsletter - 11.20.2024
PLUS: How Streamlined Is Your Training? Take this Free Quiz to Find Out!
Follow us on LinkedIn🔗
Imagine this: You’re in the middle of a product demo for a new medical device with a major healthcare provider when a junior rep interrupts, needing help understanding the specs. Suddenly, instead of sealing the deal, you’re pulled into an impromptu training session. 🩺
This scenario happens all too often. Health product companies report a 30% drop in sales productivity when experienced reps are side-lined to train new hires instead of focusing on clients (Forrester, 2023).
The fix? Use scenario-based onboarding specific to the health products sector. By training through real-world product demos and case studies, new hires get up to speed fast, freeing your top reps to focus on client relationships and driving sales.
Curious about your current onboarding effectiveness? Try Hive Perform’s Sales Readiness Assessment for a personalized review and actionable feedback.
"With Hive Perform, we cut the ramp-up time for new reps by half, hitting revenue targets in just 35 days."

INDUSTRY INSIGHTS 🌐
Digital advertising is vital for pharma brands to effectively reach healthcare professionals and patients. Leveraging platforms like LinkedIn for precise targeting and SEM for keyword-specific ads ensures impactful, compliant campaigns that engage the right audience.
Programmatic advertising optimizes budgets by using AI for real-time ad placements, while social media platforms like Facebook and Instagram drive awareness and connect with patient communities.
Tracking success with tools like Google Analytics helps measure engagement and refine strategies. Mobile optimization and embracing trends like voice search and AI-driven content provide a competitive edge.
Pharma professionals in 2025 can enhance networking through affordable strategies like leveraging virtual platforms, engaging in webinars, optimizing LinkedIn profiles, and using CRM tools. These methods, combining digital and traditional approaches, facilitate effective connections without high costs, emphasizing the importance of being known in the industry.

INDUSTRY NEWS 📰
Teva Pharmaceuticals and Immunai have partnered to enhance clinical trials in immunology and immuno-oncology. Utilizing Immunai's AI tools, the collaboration aims to optimize drug mechanisms, dose selection, and biomarker analysis. This partnership seeks to streamline drug development, improving patient outcomes and advancing Teva's research capabilities.
Madrigal Pharmaceuticals' approval of Rezdiffra, the first MASH drug, is a game-changer, solidifying its market leadership and paving the way for competitors like Inventiva Pharma. Inventiva’s lanifibranor, now in phase 3 trials, shows promise in reducing hepatic fat and fibrosis biomarkers.
Rezdiffra’s strong sales highlight the growing demand for MASH treatments. Meanwhile, GLP-1s, like Novo Nordisk’s semaglutide, show potential but face side effect challenges, creating opportunities for complementary drugs like lanifibranor, which directly targets fibrosis.
With a unique mechanism targeting three PPAR isoforms, lanifibranor is a standout in the MASH market. Inventiva’s commitment to unmet needs positions it to significantly impact treatment options and attract major pharmaceutical interest.
SBC Medical Group Holdings plans to acquire Aesthetic Healthcare Holdings in Singapore, marking its first step in expanding its aesthetic medical services in Asia. This strategic move aims to leverage Singapore's market advantages, enhancing SBC's global presence and fostering growth in the U.S. and Asian markets.


Sales Intelligence is a Contentive publication in the Sales & Marketing division